Status:
ENROLLING_BY_INVITATION
The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life
Lead Sponsor:
Aarhus University Hospital
Collaborating Sponsors:
University of Aarhus
National Research Center for Survivorship and Late Adverse Effects Following Pelvic Organ Cancer, Denmark
Conditions:
Bladder Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Bladder Cancer prognosis, treatment, and subsequent morbidity and mortality vary between the different stages, thus resulting in a different impact on patients' lives. There are some well known late e...
Eligibility Criteria
Inclusion
- Patients are eligible if they are referred to a hospital in the Central Region Denmark, due to hematuria between 01/01/2022 and 01/01/2023
- Ability to understand written and oral Danish
Exclusion
- Known Alzheimers disease
- Diagnosed other causes explaining the hematuria
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05195515
Start Date
January 1 2022
End Date
December 31 2027
Last Update
August 1 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Urology, Aarhus University Hospital
Aarhus N, Denmark, 8200
2
Department of Urology, Regional Hospital Gødstrup
Gødstrup, Denmark, 7400
3
Department of Urology, Regional Hospital Horsens
Horsens, Denmark, 8700
4
Department of Urology, Regional Hospital Randers
Randers, Denmark, 8900